Steven C. Halladay
Keine laufenden Positionen mehr
Profil
Steven C.
Halladay served as President & CEO of Research Services, Inc. from 1995 to 2001.
He was also Senior Executive Vice President of Clingenix, Inc. from 2000 to 2002.
In addition, he held the position of Vice President-Clinical & Regulatory Affairs at DURECT Corp.
from 2002 to 2006 and SVP-Clinical & Regulatory Affairs at Questcor Pharmaceuticals, Inc. He received his undergraduate degree from Southern Utah University and his graduate and doctorate degrees from the University of Arizona.
Ehemalige bekannte Positionen von Steven C. Halladay
| Unternehmen | Position | Ende |
|---|---|---|
| DURECT CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2006 |
Clingenix, Inc.
 Clingenix, Inc. Miscellaneous Commercial ServicesCommercial Services Clingenix, Inc. provided pharmacogenomics services and diagnostic products. The company was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01.01.2002 |
Research Services, Inc.
 Research Services, Inc. Miscellaneous Commercial ServicesCommercial Services Research Services, Inc. provides clinical trials, regulatory affairs, compliance, and resource services to pharmaceutical companies. Research Services was acquired by Clingenix, Inc. on July 10, 2000. | Präsident | 01.01.2001 |
| QUESTCOR PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Steven C. Halladay
| Southern Utah University | Undergraduate Degree |
| University of Arizona | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DURECT CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Clingenix, Inc.
Clingenix, Inc. Miscellaneous Commercial ServicesCommercial Services Clingenix, Inc. provided pharmacogenomics services and diagnostic products. The company was headquartered in Sunnyvale, CA. | Commercial Services |
Research Services, Inc.
Research Services, Inc. Miscellaneous Commercial ServicesCommercial Services Research Services, Inc. provides clinical trials, regulatory affairs, compliance, and resource services to pharmaceutical companies. Research Services was acquired by Clingenix, Inc. on July 10, 2000. | Commercial Services |
